ArticleEndocrine-related cancer2026
STING expression in pituitary neuroendocrine tumour immune microenvironments.
Article in Endocrine-related cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pituitary neuroendocrine tumour (PitNET) immune microenvironment (IME) has become a recent focus of research interest. Multiplex immunofluorescence combined with digital image analysis is a powerful technique to interrogate the IME. Processes such as DNA damage response and cellular senescence have been implicated in somatotroph tumour pathogenesis, and these have in turn been linked with immunological responses to neoplasia. The objectives of this study were to compare the immune cell infiltrate in PitNETs to normal pituitary, investigate how the PitNET-IME may vary according to treatment with somatostatin receptor ligand, tumour invasiveness, tumour proliferation, and AIP mutation status. Two bespoke multiplex panels were developed and applied to a range of PitNET subtypes before being interrogated with deep learning algorithms and QuPath image analysis software. Tumours had significantly higher total macrophage infiltrate (P < 0.001), STING+ macrophages (P < 0.001) and STING positivity (P < 0.001) compared with normal pituitary tissue. Macrophage infiltration and STING positivity were positively correlated with tumour Ki-67 proliferation index (rs = 0.305, P = 0.003; and rs = 0.263, P = 0.010, respectively). Results suggested that AIP-mutated PitNETs may have higher CD8+ T-lymphocyte infiltrate, macrophage infiltrate, including STING+ macrophages and overall STING positivity compared with AIP-negative tumours. The application of machine learning to multiplex immunofluorescence images identifies macrophages and STING as upregulated in these subgroups of functioning PitNETs. This immunological response may indicate that DNA damage, cellular senescence and autophagy could be features of these tumours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.